These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17531629)

  • 1. ERCP and prophylactic pancreatic stents: raising the bar, reducing the pain.
    Silverman WB
    Gastrointest Endosc; 2007 Jun; 65(7):969-70. PubMed ID: 17531629
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis.
    Das A; Singh P; Sivak MV; Chak A
    Gastrointest Endosc; 2007 Jun; 65(7):960-8. PubMed ID: 17331513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
    Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
    Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Freeman ML
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1354-65. PubMed ID: 17981248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporary prophylactic pancreatic stents: which patients need them?
    Elta GH
    Gastrointest Endosc; 2008 Feb; 67(2):262-4. PubMed ID: 18226688
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results.
    Saad AM; Fogel EL; McHenry L; Watkins JL; Sherman S; Lazzell-Pannell L; Lehman GA
    Gastrointest Endosc; 2008 Feb; 67(2):255-61. PubMed ID: 18028920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial.
    Tsuchiya T; Itoi T; Sofuni A; Itokawa F; Kurihara T; Ishii K; Tsuji S; Kawai T; Moriyasu F
    J Hepatobiliary Pancreat Surg; 2007; 14(3):302-7. PubMed ID: 17520207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanical prevention of post-ERCP pancreatitis by pancreatic stents: results, techniques, and indications.
    Tarnasky PR
    JOP; 2003 Jan; 4(1):58-67. PubMed ID: 12555017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of physician practices on prophylactic pancreatic stents.
    Brackbill S; Young S; Schoenfeld P; Elta G
    Gastrointest Endosc; 2006 Jul; 64(1):45-52. PubMed ID: 16813802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.
    Sofuni A; Maguchi H; Itoi T; Katanuma A; Hisai H; Niido T; Toyota M; Fujii T; Harada Y; Takada T
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1339-46. PubMed ID: 17981247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-ERCP pancreatitis in pediatric patients.
    Iqbal CW; Baron TH; Moir CR; Ishitani MB
    J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):430-4. PubMed ID: 20032630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In patients undergoing precut biliary sphincterotomy during endoscopic retrograde cholangiopancreatography (ERCP) to facilitate biliary access, is endoscopic pancreatic duct stenting indicated to prevent pancreatitis?].
    Igea Arisqueta F
    Gastroenterol Hepatol; 2009 Mar; 32(3):171-2. PubMed ID: 19231033
    [No Abstract]   [Full Text] [Related]  

  • 13. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis.
    Dumonceau JM; Andriulli A; Deviere J; Mariani A; Rigaux J; Baron TH; Testoni PA;
    Endoscopy; 2010 Jun; 42(6):503-15. PubMed ID: 20506068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and management of adverse events of endoscopic retrograde cholangiopancreatography.
    Balmadrid B; Kozarek R
    Gastrointest Endosc Clin N Am; 2013 Apr; 23(2):385-403. PubMed ID: 23540966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-ERCP pancreatitis: review of current preventive strategies.
    Feurer ME; Adler DG
    Curr Opin Gastroenterol; 2012 May; 28(3):280-6. PubMed ID: 22450899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the incidence and severity of post ERCP pancreatitis.
    Murray WR
    Scand J Surg; 2005; 94(2):112-6. PubMed ID: 16111092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pancreatic stent caliber on post-endoscopic retrograde cholangiopancreatogram pancreatitis rates in patients with confirmed sphincter of Oddi dysfunction.
    Ramesh J; Kim H; Reddy K; Varadarajulu S; Wilcox CM
    J Gastroenterol Hepatol; 2014; 29(7):1563-7. PubMed ID: 24617703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic prevention of post-ERCP pancreatitis: is nitroglycerin a sangreal?
    Muralidharan V; Jamidar P
    Gastrointest Endosc; 2006 Sep; 64(3):358-60. PubMed ID: 16923482
    [No Abstract]   [Full Text] [Related]  

  • 19. Pancreatic stents for prevention of post-ERCP pancreatitis: for everyday practice or for experts only?
    Freeman ML
    Gastrointest Endosc; 2010 May; 71(6):940-4. PubMed ID: 20438883
    [No Abstract]   [Full Text] [Related]  

  • 20. Pancreatic stents.
    Deviere J
    Gastrointest Endosc Clin N Am; 2011 Jul; 21(3):499-510, ix. PubMed ID: 21684467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.